The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) Region-Current status and needs

Vaccine

Volumn 25, Issue 11, 2007, Pages 1935-1944

  Hausdorff, William P ^a   Hajjeh, Rana ^b,c   Al Mazrou, Abdulrahman ^d   Shibl, Atef ^d   Soriano Gabarro, Montse ^a  

^a GSK   (Belgium)

^b US Naval Medical Research Unit No 3 Egypt   (Egypt)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Meningitis; Middle east; Pneumonia; Surveillance

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN DERIVATIVE; STREPTOCOCCUS VACCINE; TETRACYCLINE;

ALGERIA; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CHILDHOOD DISEASE; DRUG FORMULATION; EGYPT; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFECTION CONTROL; JORDAN; LEBANON; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NORTH AFRICA; OMAN; OTITIS MEDIA; PAKISTAN; PRIORITY JOURNAL; QATAR; REVIEW; SAUDI ARABIA; SCHOOL HEALTH SERVICE; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TUNISIA; UNITED ARAB EMIRATES; VACCINATION;

ADOLESCENT; ADULT; AFRICA, NORTHERN; CHILD; CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HUMANS; INFANT; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MIDDLE EAST; PNEUMOCOCCAL INFECTIONS;

EID: 33846874574     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.018     Document Type: Review

References (45)

1. WHO. Control of epidemic meningococcal disease, 2nd ed. WHO practical guidelines; 1998.
2. CDC. Pneumococcal disease. In Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book); 2004.
3. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30 (2000) 100-121
4. WHO. Pneumococcal vaccines. World Health Organization. Immunization, Vaccines and Biologicals. Available at: www.who.int/vaccines/en/pneumococcus.shtml.
5. Fedson D.S., and Scott J.A. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17 Suppl. 1 (1999) S11-S18
6. WHO. Haemophilus influenzae type B vaccine. World Health Organization. Immunization, Vaccines and Biologicals. Available at: www.who.int/vaccines/en/haeflub.shtml.
7. Rosenstein N.E., Perkins B., Stephens D.S., Popovic T., and Hughes J.M. Meningococcal disease. N Engl J Med 344 18 (2001) 1378-1387
8. WHO. Meningococcal vaccine. World Health Organization. Immunization, Vaccines and Biologicals. Available at: www.who.int/vaccines/en/meningococcus.shtml.
9. Campagne G., Schuchat A., Djibo S., Ousseini A., Cisse L., and Chippaux J.P. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bull World Health Org 77 6 (1999) 499-508
10. Schrag SJ, Beall B, Dowell S. Resistant pneumococcal infections: the burden of disease and challenges in monitoring and controlling antimicrobial resistance. WHO 2001. Available at: http://www.who.int/csr/resources/publications/drugresist/WHO_CDS_CSR_DRS_2001_6/en/.
11. Adegbola R., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of H. influenzae type b (Hib) from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366 (2005) 144-150
12. Black S., Shinefield H., Baxter R., Austrian R., Bracken L., Hansen J., et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 23 6 (2004) 485-489
13. Ramsay M.E., Andrews N., Kaczmarski E.B., and Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357 9251 (2001) 195-196
14. Kyaw M.H., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A., et al. Active bacterial core surveillance of the emerging infections program network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 14 (2006) 1455-1463
15. Hib Initiative. Countries with Hib vaccination programs. Available at www.hibaction.org/statusmap.html.
16. WHO. Country profiles. Immunisation monitoring; 2005. Available at: http://www.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm.
17. Ramdani-Bouguessa N., and Rahal K. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers. Algeria Antimicrob Agents Chemother 47 2 (2003) 824-826
18. Youssef F.G., El-Sakka H., Azab A., Eloun S., Chapman G.D., Ismail T., et al. Etiology, antimicrobial susceptibility profiles, and mortality associated with bacterial meningitis among children in Egypt. Ann Epidemiol 14 1 (2004) 44-48
19. Faraq H.M., Abdel-Fattah M.M., and Youssri A.M. Epidemiological, clinical and prognostic profile of acute bacterial meningitis among children in Alexandria. Egypt Indian J Med Microbiol 2 23 (2005) 95-101
20. Nakhla I., Frenck Jr. R.W., Teleb N.A., Oun S.E., Sultan Y., Mansour H., et al. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. Vaccine 23 25 (2005) 3288-3293
21. Wasfy M.O., Pimentel G., Abdel-Maksoud M., Russell K.L., Barrozo C.P., Klena J.D., et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother 55 6 (2005) 958-964
22. Girgis N.I., Sippel J.E., Kilpatrick M.E., Sanborn W.R., Mikhail I.A., Cross E., et al. Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg 48 (1993) 97-107
23. Ministry of Health of Jordan Website. http://www.moh.gov.jo/eheader_page.htm.
24. Daoud A.S., al-Sheyyab M., Batchoun R.G., Rawashdeh M.O., Nussair M.M., and Pugh R.N. Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood. J Trop Pediatr 41 5 (1995) 308-310
25. Matar G.M., Sidani N., Fayad M., and Hadi U. Two-step PCR-based assay for identification of bacterial etiology of otitis media with effusion in infected lebanese children. J Clin Microbiol 36 5 (1998) 1185-1188
26. Rabbani M.A., Khan A.A., Ali S.S., Ahmad B., Baig S.M., Khan M.A., et al. Spectrum of complications and mortality of bacterial meningitis: an experience from a developing country. J Pak Med Assoc 53 12 (2003) 580-583
27. Shaikh S.U., Shaikh R.B., and Faiz M.S. Seasonal paradox in acute Meningitis at Nawabshah. J Coll Physicians Surg Pak 13 4 (2003) 207-209
28. Kakar B.A., Shakoor Q.A., Abbasi K., Haq S., and Ahmed J. Laboratory diagnosis and prevalence of most common micro-organisms of acute pyogenic meningitis in L.M.C. Hospital Jamshoro, Hyderabad. Pakistan. J Med Res 39 4 (2000) 159-164
29. Mastro T.D., Ghafoor A., Nomani N.K., Ishaq Z., Anwar F., Granoff D.M., et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 337 (1991) 156-159
30. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 13 2 (2000) 302-317
31. Elsaid M.F., Alsoub H., Bessisso M.S., and Elshaffie S.S. Clinical presentation of acute bacterial meningitis in Qatar. Neurosciences 7 (2002) 266-271
32. Ahmed Q.A., Arabi Y.M., and Memish Z.A. Health risks at the Hajj. Lancet 367 9515 (2006) 1008-1015
33. Al-Binali A.M., and Al-Fifi S.H. Profile of childhood meningitis in a hospital in South West Saudi Arabia. Saudi Med J 23 7 (2002) 793-796
34. Al-Mazrou Y., Musa E., Abdalla M., Al-Jeffri M., Al-Hajjar S., and Mohamed O. Disease burden and case management of bacterial meningitis among children under 5 years of age in Saudi Arabia. Saudi Med J 24 12 (2003) 1300-1307
35. Lingappa J.R., Al-Rabeah A.M., Hajjeh R., Mustafa T., Fatani A., Al-Bassam T., et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9 (2003) 665-671
36. Al-Mazrou Y., Al-Jeffri M., Abdalla M., Elgizouli S., and Mishskas A. Changes in epidemiological pattern of meningococcal disease in Saudi Arabia-Does it constitute a new challenge for prevention and control?. Saudi Med J 25 10 (2004) 1410-1413
37. Al-Mazrou A., Twum-Danso K., Al Zamil F., and Kambal A. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines. Ann Saudi Med 25 2 (2005) 94-99
38. Thabet L., Boutiba I., Kammoun A., Khelif L., Mahjoubi F., Smaoui H., et al. Epidemilogical profile of Haemophilus influenzae infection in Tunisia. Tunis Med 80 (2002) 469-472
39. Mezghani Mallej S., Kassis M., Rhimi F.M., Damak J., and Hammami A. Bacteriologie des meningitis communautaires dans la region de Sfax, Tunisie (1993-2001). Medecine et Maladies Infectieuses 36 (2006) 105-110
40. Mahmoud R., Mahmoud M., Badrinath P., Sheek-Hussein M., Alwash R., and Nicol A.G. Pattern of meningitis in Al-Ain medical district, United Arab Emirates-a decadal experience (1990-1999). J Infect 44 (2002) 22-25
41. United Arab Emirates Ministry of Health WebSite: http://www.moh.gov.ae/moh_site/stat_plan/stat_book/english_version/index4/uae1072.pdf.
42. Obaro S.K., and Madhi S.A. Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?. Lancet Infect Dis 6 (2006) 150-161
43. Berkley J.A., Lowe B.S., Mwangi I., Williams T., Bauni E., Mwarumba S., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352 (2005) 39-47
44. WHO. Weekly Epidemiological Record, No. 1, January 2006.
45. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748